2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection,Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection,Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
复制标题

DOI:
10.1161/hyp.0000000000000065
复制
发表时间:
2018-08-01
期刊:
Journal of the American Society of Hypertension : JASH
影响因子:
--
通讯作者:
Wright, Jackson T Jr
Wright, Jackson T Jr
中科院分区:
其他
文献类型:
--
作者:
Whelton, Paul K;Carey, Robert M;Wright, Jackson T Jr

文献摘要

被引文献

相似文献

早在 20 年代,以及随后在 1959 年对 1934 年至 1954 年间近 500 万成年人进行的体质和血压研究 (S1.5-1) 中,人们就注意到血压水平与临床并发症和死亡风险之间存在密切的直接关系。 20 世纪 60 年代,弗雷明汉心脏研究 (S1.5-2) 的一系列报告证实了这些发现。 1967 年和 1970 年退伍军人管理局合作研究小组的报告开创了高血压有效治疗的时代(S1.5-3、S1.5-4)。第一个关于高血压检测、评估和管理的综合指南于 1977 年在 NHLBI 的赞助下出版(S1.5-5)。随后几年,发布了一系列国家联合委员会 (JNC) 血压指南,以协助实践界并提高高血压的预防、认识、治疗和控制 (S1.5-5—S1.5-7)。本指南更新了之前的 JNC 报告。
As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship was noted between level of BP and risk of clinical complications and death. In the 1960s, these findings were confirmed in a series of reports from the Framingham Heart Study (S1. 5-2). The 1967 and 1970 Veterans Administration Cooperative Study Group reports ushered in the era of effective treatment for high BP (S1. 5-3, S1. 5-4). The first comprehensive guideline for detection, evaluation, and management of high BP was published in 1977, under the sponsorship of the NHLBI (S1. 5-5). In subsequent years, a series of Joint National Committee (JNC) BP guidelines were published to assist the practice community and improve prevention, awareness, treatment, and control of high BP (S1. 5-5—S1. 5-7). The present guideline updates prior JNC reports.